top of page

Rare & Complex Disease

Image by National Cancer Institute

Next-Generation Sequencing (NGS) has become a pivotal tool in unraveling the genetic underpinnings of rare and complex diseases, offering unprecedented insights that transform diagnosis, treatment, and understanding. By efficiently sequencing vast stretches of DNA, NGS enables the identification of novel and rare genetic variations responsible for these conditions, often where traditional methods fall short. This capability facilitates early, accurate diagnoses, significantly impacting patient care by guiding personalized treatment strategies and avoiding lengthy diagnostic odysseys. Furthermore, NGS's ability to analyze multiple genes simultaneously at a lower cost is particularly advantageous for complex diseases that may involve several genetic factors. As a result, NGS not only accelerates the path to targeted therapies but also enhances our understanding of disease mechanisms, fostering the development of innovative treatments and management strategies for rare and complex disorders.

Related NGS Solutions

  • Clinical Whole Exome Sequencing

  • Target Region Sequencing

  • Whole Transcriptome Sequencing (WTS)

  • Whole Genome Bisulfite Sequencing (WGBS)

  • Reduced-Representation Bisulfite Sequencing (RRBS)

  • RNA Immunoprecipitation Sequencing (RIP-seq)

  • Chromatin Immunoprecipitation Sequencing (ChIP-seq)

More Applications

bottom of page